- Effectiveness in Switching from Antipsychotic Polypharmacy to Monotherapy in Patients with Schizophrenia: A Case Series
-
Kamei H, Yamada H, Hatano M, Hanya M, Yamada S, Iwata N
- KMID: 2502138
- Clin Psychopharmacol Neurosci.
- 2020 Feb;18(1):159-163.
- doi: 10.9758/cpn.2020.18.1.159
In Japan, drug therapy for schizophrenia is characterized by high-dose antipsychotic polypharmacy, which is an uncommon approach internationally. In this study, we reduced the number of antipsychotic agents in 5... -
- CITED
-
- Close
- SHARE
-
- Close
- Acceptance of the Deltoid Muscle Injection of Aripiprazole Long-acting Injectable in the Patients with Schizophrenia
-
Kamei H, Homma Y, Takeuchi I, Hajitsu G, Tozawa K, Hatano M, Fukui A, Hanya M, Yamada S, Iwata N
- KMID: 2502126
- Clin Psychopharmacol Neurosci.
- 2020 Feb;18(1):49-57.
- doi: 10.9758/cpn.2020.18.1.49
Objective: To improve poor medication adherence in schizophrenic patients, long-acting injectable (LAI) antipsychotics are used. However, it has not yet become common in Japan. Recently, aripiprazole LAI was approved for... -
- CITED
-
- Close
- SHARE
-
- Close
- Assessment of Switching to Suvorexant versus the Use of Add-on Suvorexant in Combination with Benzodiazepine Receptor Agonists in Insomnia Patients: A Retrospective Study
-
Hatano M, Kamei H, Inagaki R, Matsuzaki , Hanya M, Yamada S, Iwata N
- KMID: 2412387
- Clin Psychopharmacol Neurosci.
- 2018 May;16(2):184-189.
- doi: 10.9758/cpn.2018.16.2.184
OBJECTIVE: Suvorexant is a novel hypnotic drug that does not interact with the conventional γ-aminobutyric acid (GABA)-A receptor. We investigated the method by which suvorexant was introduced in insomnia patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Serum Levels of Brain-Derived Neurotrophic Factor at 4 Weeks and Response to Treatment with SSRIs
-
Yoshimura , Kishi T, Hori H, Katsuki A, Sugita-Ikenouchi A, Umene-Nakano W, Atake K, Iwata N, Nakamura J
- KMID: 2316335
- Psychiatry Investig.
- 2014 Jan;11(1):84-88.
OBJECTIVE: It is important to predict a response to an antidepressant in early time after starting the antidepressant. We previously reported that serum brain-derived neurotrophic factor (BDNF) levels in responders... -
- CITED
-
- Close
- SHARE
-
- Close
- Satisfaction Survey on Antipsychotic Formulations by Schizophrenia Patients in Japan
-
Hatano M, Takeuchi I, Yamashita K, Morita A, Tozawa K, Sakakibara T, Hajitsu G, Hanya M, Yamada S, Iwata N, Kamei H
- KMID: 2522958
- Clin Psychopharmacol Neurosci.
- 2021 Nov;19(4):610-617.
- doi: 10.9758/cpn.2021.19.4.610
Objective: To identify factors affecting adherence to medication, a subjective questionnaire survey was administered to schizophrenia patients regarding the prescribed antipsychotic formulations. Methods: We evaluated the patients’ satisfaction and dissatisfaction with... -
- CITED
-
- Close
- SHARE
-
- Close
- Assessment of the Latent Adverse Events of Antipsychotic Treatment Using a Subjective Questionnaire in Japanese Patients with Schizophrenia
-
Hatano M, Kamei H, Kato A, Takeuchi I, Hanya M, Uno J, Yamada S, Fujita K, Iwata N
- KMID: 2378481
- Clin Psychopharmacol Neurosci.
- 2017 May;15(2):132-137.
- doi: 10.9758/cpn.2017.15.2.132
OBJECTIVE: The adverse effects of antipsychotic agents can have a marked influence on medication adherence. In this study, we investigated the adverse events of antipsychotics that are less likely to... -
- CITED
-
- Close
- SHARE
-
- Close
- Pathogenesis and Bone Resorption in Acquired Cholesteatoma: Current Knowledge and Future Prospectives
-
Hamed MA, Nakata S, Sayed RH, Ueda H, Badawy BS, Nishimura , Kojima T, Iwata N, Ahmed AR, Dahy K, Kondo N, Suzuki K
- KMID: 2360759
- Clin Exp Otorhinolaryngol.
- 2016 Dec;9(4):298-308.
- doi: 10.21053/ceo.2015.01662
Cholesteatoma is a cystic non tumorous lesion of the temporal bone that has the ability to destroy nearby structures by its power to cause bone resorption and as a result,... -
- CITED
-
- Close
- SHARE
-
- Close
- No Association between the Response to the Addition of an Atypical Antipsychotic Drug to an SSRI or SNRI and the BDNF (Val66Met) Polymorphism in Refractory Major Depressive Disorder in Japanese Patients
-
Yoshimura , Kishi T, Hori H, Ikenouchi-Sugita A, Umene-Nakano W, Katsuki A, Hayashi K, Iwata N, Nakamura J
- KMID: 2134674
- Clin Psychopharmacol Neurosci.
- 2012 Apr;10(1):49-53.
OBJECTIVE: This study examined the association between the brain-derived neurotrophic factor (BDNF) (Val66Met) polymorphism and the response to the addition of an atypical antipsychotic drug to a selective serotonin reuptake... -
- CITED
-
- Close
- SHARE
-
- Close
- Cytokeratin 13, Cytokeratin 17, and Ki-67 Expression in Human Acquired Cholesteatoma and Their Correlation With Its Destructive Capacity
-
Hamed MA, Nakata S, Shiogama K, Suzuki K, Sayed RH, Nishimura , Iwata N, Sakurai K, Badawy BS, Inada K, Tsuge H, Tsutsumi Y
- KMID: 2395734
- Clin Exp Otorhinolaryngol.
- 2017 Sep;10(3):213-220.
- doi: 10.21053/ceo.2016.01263
OBJECTIVES: Cholesteatoma is a nonneoplastic destructive lesion of the temporal bone with debated pathogenesis and bone resorptive mechanism. Both molecular and cellular events chiefly master its activity. Continued research is... -
- CITED
-
- Close
- SHARE
-
- Close
- Phenotypic characteristics of pediatric inflammatory bowel disease in Japan: results from a multicenter registry
-
Arai K, Kunisaki R, Kakuta F, Hagiwara Si, Murakoshi T, Yanagi T, Shimizu T, Kato S, Ishige T, Aomatsu T, Inoue M, Saito T, Iwama I, Kawashima H, Kumagai H, Tajiri H, Iwata N, Mochizuki T, Noguchi A, Kashiwabara T, Shimizu H, Suzuki Y, Hirano Y, Fujiwara T
- KMID: 2508568
- Intest Res.
- 2020 Oct;18(4):412-420.
- doi: 10.5217/ir.2019.00130
Background/Aims: There are few published registry studies from Asia on pediatric inflammatory bowel disease (IBD). Registry network data enable comparisons among ethnic groups. This study examined the characteristics of IBD... -
- CITED
-
- Close
- SHARE
-
- Close
